Caption
: Recruiting trial
= 
; Ongoing trial
= 
-
- GERMANY
- Berlin
- NOT YET IDENTIFIED - DE
- A phase I/III open-label, multicenter, crossover safety, efficacy and pharmacokinetic study of Recombinant Coagulation Factor VIII compared to Recombinant Human Antihemophilic Factor VIII in Subjects with Hemophilia A, and a repeat prekallikrein - DE
- Not yet identified - DE
- More details
-
- SPAIN
- Madrid
- NOT YET IDENTIFIED - ES
- Leopold I: A Two Part Randomized Cross-Over Trial to Evaluate the Pharmacokinetics, Efficacy, and Safety Profile of Plasma Protein-Free Recombinant FVIII Formulated With Sucrose (BAY81-8973) in Previously Treated Subjects With Severe Hemophilia A Under Prophylaxis Therapy (Phase III) - ES
- Not yet identified - ES
- More details
-
- SPAIN
- Madrid
- NOT YET IDENTIFIED - ES
- Randomized, Active-controlled, Double-blind, Parallel Design Study to Evaluate the Efficacy and Safety of a Once-a-week Prophylaxis Treatment With BAY 79-4980 Compared to Three Times-per-week Prophylaxis With rFVIII-FS in Previously Treated Patients With Severe Hemophilia A (Phase II) (completed)
- Not yet identified - ES
- More details
-
- SPAIN
- Madrid
- NOT YET IDENTIFIED - ES
- Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery - NO PEACKS (Phase IV) (completed)
- Not yet identified - ES
- More details
